<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="case-report" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Iran Biomed J</journal-id>
<journal-id journal-id-type="iso-abbrev">Iran. Biomed. J</journal-id>
<journal-title-group>
<journal-title>Iranian Biomedical Journal</journal-title>
</journal-title-group>
<issn pub-type="ppub">1028-852X</issn>
<issn pub-type="epub">2008-823X</issn>
<publisher>
<publisher-name>Pasteur Institute</publisher-name>
<publisher-loc>Iran</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27452399</article-id>
<article-id pub-id-type="pmc">5075143</article-id>
<article-id pub-id-type="publisher-id">IBJ-20-295</article-id>
<article-id pub-id-type="doi">10.22045/ibj.2016.07</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Case Report</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Whole Exome Sequencing Reveals a <italic>BSCL2</italic> Mutation Causing Progressive Encephalopathy with Lipodystrophy (PELD) in an Iranian Pediatric Patient</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Alaei</surname>
<given-names>Mohammad Reza</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Talebi</surname>
<given-names>Saeed</given-names>
</name>
<xref ref-type="aff" rid="aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ghofrani</surname>
<given-names>Mohammad</given-names>
</name>
<xref ref-type="aff" rid="aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Taghizadeh</surname>
<given-names>Mohsen</given-names>
</name>
<xref ref-type="aff" rid="aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Keramatipour</surname>
<given-names>Mohammad</given-names>
</name>
<xref ref-type="aff" rid="aff2">2</xref>
<xref ref-type="corresp" rid="cor1">*</xref>
</contrib>
</contrib-group>
<aff id="aff1"><label>1</label>Department of Pediatric Endocrinology, Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran</aff>
<aff id="aff2"><label>2</label>Department of Medical Genetics, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran</aff>
<author-notes>
<corresp id="cor1"><bold>Corresponding Author:</bold> Mohammad Keramatipour Department of Medical Genetics, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran; Tel/Fax: (+98-21) 64053213; E-mail: <email xlink:href="keramatipour@tums.ac.ir">keramatipour@tums.ac.ir</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<month>11</month>
<year>2016</year>
</pub-date>
<volume>20</volume>
<issue>5</issue>
<fpage>295</fpage>
<lpage>301</lpage>
<history>
<date date-type="received">
<day>05</day>
<month>3</month>
<year>2016</year>
</date>
<date date-type="rev-recd">
<day>08</day>
<month>3</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>09</day>
<month>3</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright: © Iranian Biomedical Journal</copyright-statement>
<copyright-year>2016</copyright-year>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0/">
<license-p><!--CREATIVE COMMONS-->This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/3.0/">http://creativecommons.org/licenses/by/3.0/</ext-link>) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>
<abstract>
<sec id="st1">
<title>Background:</title>
<p>Progressive encephalopathy with or without lipodystrophy is a rare autosomal recessive childhood-onset seipin-associated neurodegenerative syndrome, leading to developmental regression of motor and cognitive skills. In this study, we introduce a patient with developmental regression and autism. The causative mutation was found by exome sequencing.</p>
</sec>
<sec id="st2">
<title>Methods:</title>
<p>The proband showed a generalized hypertonia and regression of all developmental milestones. Based on the advantages of next-generation sequencing (NGS), whole exome sequencing (WES) was requested. The functional significance of variants was evaluated by NGS-specific prediction servers. Sanger sequencing was used for segregation analysis in the family.</p>
</sec>
<sec id="st3">
<title>Results:</title>
<p>There was no specific sign in the clinical and paraclinical investigations of the patient to establish a conclusive clinical diagnosis. WES detected a known homozygous nonsense mutation in <italic>BSCL2</italic> (NM_001122955.3:c. 985C&gt;T; p.Arg329*). The variant is segregating in the pedigree with an autosomal recessive pattern.</p>
</sec>
<sec id="st4">
<title>Conclusion:</title>
<p>Exome sequencing is a robust method for identifying the candidate gene variants in Mendelian traits.</p>
</sec>
</abstract>
<kwd-group>
<kwd>Exome</kwd>
<kwd>
<italic>BSCL2</italic>
</kwd>
<kwd>Seipin</kwd>
<kwd>Iran</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="sec1-1" sec-type="intro">
<title>INTRODUCTION</title>
<p><italic>B</italic><italic>SCL2</italic> (Berardinelli-Seip congenital lipo-dystrophy 2; OMIM: 606158) was first identified in BSCL2 patients in 2001 [<xref ref-type="bibr" rid="ref1">1</xref>]. The gene, which is also called seipin, is located on chromosome 11q13 and contains 11 exons. It has been revealed through Northern blot analysis that <italic>BSCL2</italic>/seipin produces three transcripts of 2.2 kb, 1.8 and 1.6 kb. The 1.8-kb mRNA is only expressed in brain and testis but the two other transcripts are expressed ubiquitously[<xref ref-type="bibr" rid="ref2">2</xref>].</p>
<p>Seipin protein has three isoforms (1-3) that are 462, 398, and 287 amino acids long, respectively[<xref ref-type="bibr" rid="ref3">3</xref>]. All three isoforms contain two hydrophobic amino acid regions predicted to be transmembrane domains. Seipin can anchor to membranes through hydrophobic interactions using these regions. In fact, seipin resides in endoplasmic reticulum where these two trans-membrane domains are buried in endoplasmic reticulum membrane. The middle part of the protein, which is conserved during evolution, is located inside the endoplasmic reticulum lumen, and both N-terminal and C-terminal domains face cytoplasm[<xref ref-type="bibr" rid="ref2">2</xref>,<xref ref-type="bibr" rid="ref4">4</xref>-<xref ref-type="bibr" rid="ref7">7</xref>]. Although the function of seipin is not completely elucidated, some researchers have shown that the protein has a role in adipogenesis, biogenesis of lipid droplets and metabolism of lipids[<xref ref-type="bibr" rid="ref8">8</xref>-<xref ref-type="bibr" rid="ref14">14</xref>]. However, others have depicted a potential neural involvement[<xref ref-type="bibr" rid="ref15">15</xref>-<xref ref-type="bibr" rid="ref18">18</xref>].</p>
<p>Mutations in <italic>BSCL2</italic>/seipin cause two distinct phenotypes. Loss-of-function mutations are responsible for congenital generalized lipodystrophy type 2 (Berardinelli-Seip syndrome type 2; OMIM: 269700). Gain-of-function mutations or gain-of-toxic function mutations in seipin gene result in neurological disorders like Silver syndrome/spastic paraplegia 17 (OMIM: 270685) and distal hereditary motor neuropathy type V (OMIM: 600794). These disorders are currently being referred to as “seipinopathies”. Patients with seipinopathies have heterogeneous symptoms and manifest both upper and lower motor neuron disruptions[<xref ref-type="bibr" rid="ref19">19</xref>].</p>
<p>Recently, a new seipin-associated neurodegenerative syndrome has been introduced by Guillén-Navarro <italic>et al</italic>.[<xref ref-type="bibr" rid="ref20">20</xref>], known as progressive encephalopathy with or without lipodystrophy (PELD; OMIM: 615924). They found six children affected with severe, progressive encephalopathy from four apparently unrelated families. All of the patients were from Murica in southeastern Spain, and the transmission pattern of the disorder was compatible with autosomal recessive inheritance.</p>
<p>Whole exome sequencing (WES) is an innovative exome-targeted technique that utilizes sequence capture technology to selectively capture the exome region within the whole genome, followed by target fragments enrichment and high-throughput sequencing. Here, we present an Iranian patient carrying the R329X mutation in the <italic>BSCL2</italic>, whose diagnosis was difficult, and finally clinical WES confirms the diagnosis of PELD.</p>
</sec>
<sec id="sec1-2" sec-type="materials|methods">
<title>MATERIALS AND METHODS</title>
<sec id="sec2-1">
<title>Subjects and clinical assessment</title>
<p>The research was reviewed and approved by a duly constituted Ethics Committee of Tehran University of Medical Sciences (Tehran, Iran). A written informed consent was obtained from parents of the patient. Blood samples from the proband and his parents were collected and processed. Clinical evaluations included standard history, physical examination, brain MRI, brain CT-Scan, and metabolic profiling.</p>
</sec>
<sec id="sec2-2">
<title>DNA extraction</title>
<p>Genomic DNA was extracted from the blood leucocytes of the proband and his parents using the QIAamp blood kit (QIAGEN, Hilden, Germany) according to the manufacturer’s protocols.</p>
</sec>
<sec id="sec2-3">
<title>Whole exome sequencing</title>
<p>WES was performed by BGI Shenzhen (Beijing Genome Institute, Shenzhen, China). Exons of DNA samples were captured using the in-solution SureSelect Target Enrichment System (Agilent, Human All Exon Kits v2; Agilent Technologies, Inc., Santa Clara, CA, USA), followed by a paired-end high-throughput sequencing on reads of 75 bp using Illumina HiSeq 2000 (Illumine Inc., San Diego, CA, USA). A 23-giga base sequence was generated with at least 98.08% coverage for 4×, 91.86% for 20×, and 85.66% for 30× of the sample. The coverage of the target region was 98.93%, and the mean depth was 90.58×. Sanger sequencing was performed to confirm the candidate variants found in WES as well as segregation analysis of the candidate variants within the family.</p>
</sec>
<sec id="sec2-4">
<title><italic>In silico</italic> pathogenicity assessment of variants</title>
<p>Non-exonic and synonymous variants were removed. The process was followed by the removal of common variants (i.e., minor allele frequency &gt;0.02) reported in the single nucleotide polymorphism database (dbSNP), the 1-k human genome, the ESP6500 and BGI in house databases. To evaluate the pathogenicity of the novel variants, we analyzed the potential impact of a given variant on the function or structure of the encoded protein. The analysis was carried out based on conservation, physical properties of the amino acids or possible occurrence in regulatory or splicing motifs using bioinformatic tools SIFT (<ext-link ext-link-type="uri" xlink:href="http://sift.jcvi.org">sift.jcvi.org</ext-link>), PolyPhen-2 (<ext-link ext-link-type="uri" xlink:href="http://genetics.bwh.harvard.edu/pph2">http://genetics.bwh.harvard.edu/pph2</ext-link>), Combined Annotation Dependent Depletion[<xref ref-type="bibr" rid="ref21">21</xref>], and MutationTaster[<xref ref-type="bibr" rid="ref22">22</xref>]. Among the prioritized variants, truncating mutations or mutations predicted to be damaging were considered to be the most promising candidates. PubMed and OMIM were reviewed for previous publications regarding candidate genes as well as functional and expression data.</p>
</sec>
</sec>
<sec id="sec1-3" sec-type="results">
<title>RESULTS</title>
<sec id="sec2-5">
<title>Clinical findings</title>
<p>The proband was a boy born at term via cesarean section (due to fetal distress) from a 25-year-old mother. The parents were first-degree cousins. Family history was unremarkable for genetic or metabolic disorders (<xref ref-type="fig" rid="F1">Fig. 1</xref>). His birth measurements (weight: 3000 g, head circumference: 36 cm and length: 49 cm) and the neonatal history were normal. Due to poor weight gain at early infancy, soy-based, lactose free formula was added to the breast feeding. He was operated for inguinal hernia at 4<sup>th</sup> month of age and was hospitalized one more time due to pneumonia at 6<sup>th</sup> month of age. His growth was within the acceptable range. The motor and cognitive developmental milestones were within the acceptable range until two years but the speech and social skills were delayed. At 2.5 years of age, ritalin was prescribed for hyperactivity. Afterwards, other developmental milestones, especially motor skills, regressed significantly. When ritalin was discontinued, his skills improved slightly but the regression continued later.</p>
<fig id="F1" position="float">
<label>Fig. 1</label>
<caption>
<p>Pedigree of the Iranian family with Progressive encephalopathy with or without lipodystrophy.</p>
</caption>
<graphic xlink:href="IBJ-20-295-g001"></graphic>
</fig>
<p>Electroencephalography demonstrated the presence of non-convulsive status epilepticus, which was intractable to anti-epileptic drugs. Convulsive epilepsy appeared later. His weight gain was poor but the height growth was normal (weight: 14 kg and height: 117 cm at 7.5 years of age). He had a history of a dry skin with excessive sweating of hand and palm. There was a generalized loss of skin fat, especially in the facial skin. In addition, there was a generalized hypertrichosis with low frontal hairline. The neurological examination showed an autistic child with repetitive and stereotypic hand movements, repetitive upward staring, ataxia, generalized hypertonia, and severe global developmental delay. Fundoscopic examination was normal. However, the death occurred at the age of eight following an episode of status epilepticus.</p>
<p>The brain CT-Scan and MRI in the 3<sup>rd</sup> year of age showed only an arachnoid cyst in the left hippocampus. Evaluation of plasma biochemical metabolites, including glucose, calcium, urea, creatinine, ammonia, lactate, blood gas, aminoacid profile, and acylcarnitine profile demonstrated no pathologic finding. Liver and thyroid function tests were also normal.</p>
</sec>
<sec id="sec2-6">
<title>Genetic findings</title>
<p>Totally, 131811 SNPs and 17317 indel variations were detected in the exome analysis (<xref ref-type="table" rid="T1">Table 1</xref>). To identify the pathogenic mutation, the exome data sequence variants were filtered step-by-step to reduce the number of potentially pathogenic variants as described above. Finally, we sorted the filtered variants according to the zygocity and Combined Annotation Dependent Depletion-PHRED score (Cut-off=15). Seven homozygous variants were found in genes like <italic>BSCL2</italic>, <italic>CEP164</italic>, <italic>HPS5</italic>, <italic>PEX16</italic>, and <italic>CHRNA3</italic> (<xref ref-type="table" rid="T2">Table 2</xref>). Only the mutation in the <italic>BSCL2</italic>, which causes PELD syndrome, was compatible with the clinical findings of the proband. The <italic>BSCL2</italic> mutation was a nonsense mutation in exon 7 of the gene (NM_001122955.3:c.985C&gt;T[p.R329X]).</p>
<table-wrap id="T1" position="float">
<label>Table 1</label>
<caption>
<p>Summary of variants detected through whole exome sequencing</p>
</caption>
<table frame="hsides" rules="groups" width="100%">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1">Variant types</th>
<th align="center" colspan="1" rowspan="1">Proband</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">Total number of variants obtained</td>
<td align="center" colspan="1" rowspan="1">149128</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Total Indel variants</td>
<td align="center" colspan="1" rowspan="1">17317</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Exonic non-synonymous variants<xref ref-type="table-fn" rid="t1f1">*</xref></td>
<td align="center" colspan="1" rowspan="1">226</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Exonic non-synonymous homozygous variants<xref ref-type="table-fn" rid="t1f1">*</xref></td>
<td align="center" colspan="1" rowspan="1">14</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Coding Indel<xref ref-type="table-fn" rid="t1f1">*</xref></td>
<td align="center" colspan="1" rowspan="1">22</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Frame shift<xref ref-type="table-fn" rid="t1f1">*</xref></td>
<td align="center" colspan="1" rowspan="1">3</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Nonsense<xref ref-type="table-fn" rid="t1f1">*</xref></td>
<td align="center" colspan="1" rowspan="1">1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Splice site<xref ref-type="table-fn" rid="t1f1">*</xref></td>
<td align="center" colspan="1" rowspan="1">1</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="t1f1">
<label>*</label>
<p>Minor allele frequency (MAF)&lt;0.02</p>
</fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="T2" position="float">
<label>Table 2</label>
<caption>
<p>Exonic homozygous variants (MAF&lt;0.02) with high CADD score</p>
</caption>
<table frame="hsides" rules="groups" width="100%">
<thead>
<tr>
<th align="center" colspan="1" rowspan="1">Gene name</th>
<th align="center" colspan="1" rowspan="1">Transcript*</th>
<th align="center" colspan="1" rowspan="1">DNA change</th>
<th align="center" colspan="1" rowspan="1">Amino Acid change</th>
<th align="center" colspan="1" rowspan="1">Fr. 1</th>
<th align="center" colspan="1" rowspan="1">Fr. 2</th>
<th align="center" colspan="1" rowspan="1">Fr. 3</th>
<th align="center" colspan="1" rowspan="1">Fr. 4</th>
<th align="center" colspan="1" rowspan="1">Raw score</th>
<th align="center" colspan="1" rowspan="1">PHRED v1.3</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>BSCL2</italic>
</td>
<td align="center" colspan="1" rowspan="1">NM_001122955.3</td>
<td align="center" colspan="1" rowspan="1">c.985C&gt;T</td>
<td align="center" colspan="1" rowspan="1">p.Arg329*</td>
<td align="center" colspan="1" rowspan="1">.</td>
<td align="center" colspan="1" rowspan="1">.</td>
<td align="center" colspan="1" rowspan="1">.</td>
<td align="center" colspan="1" rowspan="1">0</td>
<td align="center" colspan="1" rowspan="1">9.94193</td>
<td align="center" colspan="1" rowspan="1">36</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>CEP164</italic>
</td>
<td align="center" colspan="1" rowspan="1">NM_014956.4</td>
<td align="center" colspan="1" rowspan="1">c.1246C&gt;T</td>
<td align="center" colspan="1" rowspan="1">p.Arg416Cys</td>
<td align="center" colspan="1" rowspan="1">.</td>
<td align="center" colspan="1" rowspan="1">.</td>
<td align="center" colspan="1" rowspan="1">.</td>
<td align="center" colspan="1" rowspan="1">0</td>
<td align="center" colspan="1" rowspan="1">5.40362</td>
<td align="center" colspan="1" rowspan="1">26</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>HPS5</italic>
</td>
<td align="center" colspan="1" rowspan="1">NM_181507.1</td>
<td align="center" colspan="1" rowspan="1">c.2866T&gt;C</td>
<td align="center" colspan="1" rowspan="1">p.Tyr956His</td>
<td align="center" colspan="1" rowspan="1">0.000693</td>
<td align="center" colspan="1" rowspan="1">.</td>
<td align="center" colspan="1" rowspan="1">0.000693</td>
<td align="center" colspan="1" rowspan="1">0</td>
<td align="center" colspan="1" rowspan="1">5.0166</td>
<td align="center" colspan="1" rowspan="1">25.2</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>HPS5</italic>
</td>
<td align="center" colspan="1" rowspan="1">NM_181507.1</td>
<td align="center" colspan="1" rowspan="1">c.1685C&gt;T</td>
<td align="center" colspan="1" rowspan="1">p.Thr562Met</td>
<td align="center" colspan="1" rowspan="1">0.0005</td>
<td align="center" colspan="1" rowspan="1">0.0005</td>
<td align="center" colspan="1" rowspan="1">.</td>
<td align="center" colspan="1" rowspan="1">0.0002</td>
<td align="center" colspan="1" rowspan="1">2.18428</td>
<td align="center" colspan="1" rowspan="1">17.41</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>PEX16</italic>
</td>
<td align="center" colspan="1" rowspan="1">NM_057174.2</td>
<td align="center" colspan="1" rowspan="1">c.760G&gt;C</td>
<td align="center" colspan="1" rowspan="1">p.Val254Leu</td>
<td align="center" colspan="1" rowspan="1">0.014096</td>
<td align="center" colspan="1" rowspan="1">0.0101</td>
<td align="center" colspan="1" rowspan="1">0.018712</td>
<td align="center" colspan="1" rowspan="1">0.0101</td>
<td align="center" colspan="1" rowspan="1">1.98294</td>
<td align="center" colspan="1" rowspan="1">16.1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>DDHD1</italic>
</td>
<td align="center" colspan="1" rowspan="1">NM_001160148.1</td>
<td align="center" colspan="1" rowspan="1">c.336_337insGGCGGC</td>
<td align="center" colspan="1" rowspan="1">p.Gly112_Ser113insGlyGly</td>
<td align="center" colspan="1" rowspan="1">0</td>
<td align="center" colspan="1" rowspan="1">.</td>
<td align="center" colspan="1" rowspan="1">.</td>
<td align="center" colspan="1" rowspan="1">.</td>
<td align="center" colspan="1" rowspan="1">1.95542</td>
<td align="center" colspan="1" rowspan="1">15.93</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>CHRNA3</italic>
</td>
<td align="center" colspan="1" rowspan="1">NM_000743.4</td>
<td align="center" colspan="1" rowspan="1">c.67_69delCTG</td>
<td align="center" colspan="1" rowspan="1">p.Leu23 del</td>
<td align="center" colspan="1" rowspan="1">0</td>
<td align="center" colspan="1" rowspan="1">.</td>
<td align="center" colspan="1" rowspan="1">.</td>
<td align="center" colspan="1" rowspan="1">.</td>
<td align="center" colspan="1" rowspan="1">1.88124</td>
<td align="center" colspan="1" rowspan="1">15.47</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>*All rare variants in OMIM disease (less than 2% in 1k human genome, dbSNP, ESP6500 or BGI in house database) are listed in this table. *The report is based on OMIM database updated on 19 January 2015. *Transcript, the ID of mRNA transcript of the gene. Mostly, we choose the longest one; Fr.1, dbSNP allele frequency; Fr.2, 1K-genome database frequency; Fr.3, ESP6500 frequency; Fr.4, BGI in-house database frequency. MAF: minor allele frequency, CADD: Combined Annotation Dependent Depletion.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>MutationTaster predicts this variant to be disease causing. This mutation was not present in dbSNP, the 1k human genome, the ESP6500 and BGI in house databases. Sanger sequencing confirmed the WES results. The proband carried the mutation homozygously, and unaffected parents were found to be heterozygous for the mutation (<xref ref-type="fig" rid="F2">Fig. 2</xref>).</p>
<fig id="F2" position="float">
<label>Fig. 2</label>
<caption>
<p>Sequencing chromatograms of the proband and his parents.</p>
</caption>
<graphic xlink:href="IBJ-20-295-g002"></graphic>
</fig>
</sec>
</sec>
<sec id="sec1-4" sec-type="discussion">
<title>DISCUSSION</title>
<p>PELD is a severe neurodegenerative disorder characterized by developmental regression of motor and cognitive skills in the first years of life and often results in patient’s death in the first decade of life. Clinical features include psychomotor regression, loss of speech, poor motor coordination with increased muscle tonicity, spasticity, ataxia, tremor, myoclonus-dystonia and seizures. A mild lipodystrophic phenotype with a lipoatrophic appearance can be found in most of the patients. Some of the affected people may have hypertriglyceridemia and hepatomegaly[<xref ref-type="bibr" rid="ref20">20</xref>]. The Iranian patient had almost all of these clinical findings, as mentioned above.</p>
<p>In this study, we presented a proband with neuro-developmental regression, in which extensive neurologic and metabolic evaluations were not sufficiently specific for the diagnosis. We decided to perform WES on the affected patient in search for homozygous and potentially damaging gene variants. Analysis of WES revealed a known homozygous Sanger validated nonsense mutation c.985C&gt;T (p.R329X) in exon 7 of the <italic>BSCL2</italic> gene related to PELD.</p>
<p>Based on the deleteriousness of the variant and the overlap between clinical features of the Iranian patient with the patients in whom the mutation was originally found, this variant was considered to be the most likely pathogenic candidate variant of the ones identified by WES. The variant is segregating in the family. PELD is an extremely rare condition; only six cases have been reported in scientific literature so far[<xref ref-type="bibr" rid="ref20">20</xref>] and, to our knowledge, this is the first report of a PELD patient from Iranian population.</p>
<p>Identification of pathogenic mutation in rare Mendelian disorders could increase the quality of clinical diagnosis, patients management, and family counseling[<xref ref-type="bibr" rid="ref23">23</xref>]. However, the establishment of a molecular diagnosis is particularly difficult in case of rare syndromes, in diseases with very high degrees of genetic and/or clinical heterogeneity and when clinical information in patients is limited or unspecific to reach to a conclusive diagnosis. Multiple studies have shown that WES technology can be beneficial to delineate the cause of the disease at DNA level and expedite the process of final clinical decision-making in situations of this nature[<xref ref-type="bibr" rid="ref24">24</xref>,<xref ref-type="bibr" rid="ref32">32</xref>].</p>
<p>In the present study, we have elucidated the genetic cause of PELD in an Iranian patient. We have also demonstrated the usefulness of WES in identifying the causative variant. This study illustrates how WES can be used in a clinical setting to identify pathogenic mutations in search for a specific diagnosis. Furthermore, WES can be used to accelerate clinical investigations of heterogeneous Mendelian traits as yet inconclusive cases.</p>
</sec>
</body>
<back>
<ack>
<title>ACKNOWLEDGEMENTS</title>
<p>This study was financially supported in part by the Center for Non-Communicable Disease Control, Ministry of Health and Medical Education (MOHME), Iran. We would like to express our deepest gratitude to Dr. Meghdad Kheirkhahan, Dr. Sadeh, Dr. Nasirian, Ms. Zahra Golchehreh, Mr. Karim Faraji, Ms. Golnaz-ensieh Kazemisefat, Ms. Nazanin-atieh Kazemisefat, Ms. Samaneh Maleknia and Ms. Masoumeh Razipour for their kind participation in this study. Our warmest thanks go to Dr. Ashraf Samavat (Genetics Office, Center for NCD Control, MOHME) for her invaluable and constructive comments and for her collaboration and kind supports.</p>
</ack>
<fn-group>
<fn fn-type="COI-statement">
<p><bold>CONFLICT OF INTEREST.</bold> None declared.</p>
</fn>
</fn-group>
<ref-list>
<title>REFERENCES</title>
<ref id="ref1">
<label>1</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>M Magre</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Delepine</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Khallouf</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Gedde-Dahl</surname>
<given-names>T</given-names>
<suffix>Jr</suffix>
</name>
<name>
<surname>Van Maldergem</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Sobel</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Papp</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Meier</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Megarbane</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bachy</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Verloes</surname>
<given-names>A</given-names>
</name>
<name>
<surname>d’Abronzo</surname>
<given-names>FH</given-names>
</name>
<name>
<surname>Seemanova</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Assan</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Baudic</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Bourut</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Czernichow</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Huet</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Grigorescu</surname>
<given-names>F</given-names>
</name>
<name>
<surname>de Kerdanet</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lacombe</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Labrune</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Lanza</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Loret</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Matsuda</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Navarro</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Nivelon-Chevalier</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Polak</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Robert</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Tric</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Tubiana-Rufi</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Vigouroux</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Weissenbach</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Savasta</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Maassen</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Trygstad</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Bogalho</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Freitas</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Medina</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Bonnicci</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Joffe</surname>
<given-names>BI</given-names>
</name>
<name>
<surname>Loyson</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Panz</surname>
<given-names>VR</given-names>
</name>
<name>
<surname>Raal</surname>
<given-names>FJ</given-names>
</name>
<name>
<surname>O’Rahilly</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Stephenson</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Kahn</surname>
<given-names>CR</given-names>
</name>
<name>
<surname>Lathrop</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Capeau</surname>
<given-names>J</given-names>
</name>
</person-group>
<collab>BSCL Working Group</collab>
<article-title>Identification of the gene altered in Berardinelli-Seip congenital lipodystrophy on chromosome 11q13</article-title>
<source/>Nature genetics
          <year>2001</year>
<volume>28</volume>
<issue>4</issue>
<fpage>365</fpage>
<lpage>370</lpage>
<pub-id pub-id-type="pmid">11479539</pub-id>
</element-citation>
</ref>
<ref id="ref2">
<label>2</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Windpassinger</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Auer-Grumbach</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Irobi</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Patel</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Petek</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Horl</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Malli</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Reed</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Dierick</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Verpoorten</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Warner</surname>
<given-names>TT</given-names>
</name>
<name>
<surname>Proukakis</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Van den Bergh</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Verellen</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Van Maldergem</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Merlini</surname>
<given-names>L</given-names>
</name>
<name>
<surname>De</surname>
<given-names>Jonghe P</given-names>
</name>
<name>
<surname>Timmerman</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Crosby</surname>
<given-names>AH</given-names>
</name>
<name>
<surname>Wagner</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Heterozygous missense mutations in BSCL2 are associated with distal hereditary motor neuropathy and Silver syndrome</article-title>
<source/>Nature genetics
          <year>2004</year>
<volume>36</volume>
<issue>3</issue>
<fpage>271</fpage>
<lpage>276</lpage>
<pub-id pub-id-type="pmid">14981520</pub-id>
</element-citation>
</ref>
<ref id="ref3">
<label>3</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cartwright</surname>
<given-names>BR</given-names>
</name>
<name>
<surname>Goodman</surname>
<given-names>JM</given-names>
</name>
</person-group>
<article-title>Seipin: from human disease to molecular mechanism</article-title>
<source/>Journal of lipid research
          <year>2012</year>
<volume>53</volume>
<issue>6</issue>
<fpage>1042</fpage>
<lpage>1055</lpage>
<pub-id pub-id-type="pmid">22474068</pub-id>
</element-citation>
</ref>
<ref id="ref4">
<label>4</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wee</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Sugii</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>W</given-names>
</name>
</person-group>
<article-title>Towards a mechanistic understanding of lipodystrophy and seipin functions</article-title>
<source/>Bioscience reports
          <year>2014</year>
<volume>34</volume>
<issue>5</issue>
<comment>doi:10.1042/BSR20140114</comment>
</element-citation>
</ref>
<ref id="ref5">
<label>5</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Irobi</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Van den Bergh</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Merlini</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Verellen</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Van</surname>
<given-names>Maldergem L</given-names>
</name>
<name>
<surname>Dierick</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Verpoorten</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Jordanova</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Windpassinger</surname>
<given-names>C</given-names>
</name>
<name>
<surname>De</surname>
<given-names>Vriendt E</given-names>
</name>
<name>
<surname>Van</surname>
<given-names>Gerwen V</given-names>
</name>
<name>
<surname>Auer-Grumbach</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Wagner</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Timmerman</surname>
<given-names>V</given-names>
</name>
<name>
<surname>De</surname>
<given-names>Jonghe P</given-names>
</name>
</person-group>
<article-title>The phenotype of motor neuropathies associated with BSCL2 mutations is broader than Silver syndrome and distal HMN type V</article-title>
<source/>Brain
          <year>2004</year>
<volume>127</volume>
<issue>Pt 9</issue>
<fpage>2124</fpage>
<lpage>2130</lpage>
<pub-id pub-id-type="pmid">15242882</pub-id>
</element-citation>
</ref>
<ref id="ref6">
<label>6</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lundin</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Nordstrom</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Wagner</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Windpassinger</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Andersson</surname>
<given-names>H</given-names>
</name>
<name>
<surname>von</surname>
<given-names>Heijne G</given-names>
</name>
<name>
<surname>Nilsson</surname>
<given-names>I</given-names>
</name>
</person-group>
<article-title>Membrane topology of the human seipin protein</article-title>
<source/>FEBS letters
          <year>2006</year>
<volume>580</volume>
<issue>9</issue>
<fpage>2281</fpage>
<lpage>2284</lpage>
<pub-id pub-id-type="pmid">16574104</pub-id>
</element-citation>
</ref>
<ref id="ref7">
<label>7</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Thein</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Venkatesh</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Sugii</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Radda</surname>
<given-names>GK</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>W</given-names>
</name>
</person-group>
<article-title>Seipin differentially regulates lipogenesis and adipogenesis through a conserved core sequence and an evolutionarily acquired C-terminus</article-title>
<source/>The biochemical journal
          <year>2013</year>
<volume>452</volume>
<issue>1</issue>
<fpage>37</fpage>
<lpage>44</lpage>
<pub-id pub-id-type="pmid">23458123</pub-id>
</element-citation>
</ref>
<ref id="ref8">
<label>8</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Payne</surname>
<given-names>VA</given-names>
</name>
<name>
<surname>Grimsey</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Tuthill</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Virtue</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Gray</surname>
<given-names>SL</given-names>
</name>
<name>
<surname>Dalla Nora</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Semple</surname>
<given-names>RK</given-names>
</name>
<name>
<surname>O’Rahilly</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Rochford</surname>
<given-names>JJ</given-names>
</name>
</person-group>
<article-title>The human lipodystrophy gene BSCL2/seipin may be essential for normal adipocyte differentiation</article-title>
<source/>Diabetes
          <year>2008</year>
<volume>57</volume>
<issue>8</issue>
<fpage>2055</fpage>
<lpage>2060</lpage>
<pub-id pub-id-type="pmid">18458148</pub-id>
</element-citation>
</ref>
<ref id="ref9">
<label>9</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fei</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Shui</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Gaeta</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Kuerschner</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Wenk</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Parton</surname>
<given-names>RG</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Fld1p, a functional homologue of human seipin, regulates the size of lipid droplets in yeast</article-title>
<source/>The journal of cell biology
          <year>2008</year>
<volume>180</volume>
<issue>3</issue>
<fpage>473</fpage>
<lpage>482</lpage>
<pub-id pub-id-type="pmid">18250201</pub-id>
</element-citation>
</ref>
<ref id="ref10">
<label>10</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Yechoor</surname>
<given-names>VK</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>BH</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>MV</given-names>
</name>
<name>
<surname>March</surname>
<given-names>KL</given-names>
</name>
<name>
<surname>Chan</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>The human lipodystrophy gene product Berardinelli-Seip congenital lipodystrophy 2/seipin plays a key role in adipocyte differentiation</article-title>
<source/>Endocrinology
          <year>2009</year>
<volume>150</volume>
<issue>10</issue>
<fpage>4552</fpage>
<lpage>4561</lpage>
<pub-id pub-id-type="pmid">19574402</pub-id>
</element-citation>
</ref>
<ref id="ref11">
<label>11</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Szymanski</surname>
<given-names>KM BD</given-names>
</name>
<name>
<surname>Bartz</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Grishin</surname>
<given-names>NV</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>WP</given-names>
</name>
<name>
<surname>Agarwal</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>Garg</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Anderson</surname>
<given-names>RG</given-names>
</name>
<name>
<surname>Goodman</surname>
<given-names>JM</given-names>
</name>
</person-group>
<article-title>The lipodystrophy protein seipin is found at endoplasmic reticulum lipid droplet junctions and is important for droplet morphology</article-title>
<source/>Proceedings of the national academy of sciences USA
          <year>2007</year>
<volume>104</volume>
<issue>52</issue>
<fpage>20890</fpage>
<lpage>20895</lpage>
</element-citation>
</ref>
<ref id="ref12">
<label>12</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cui</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Deng</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Ju</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Seipin ablation in mice results in severe generalized lipodystrophy</article-title>
<source/>Human molecular genetics
          <year>2011</year>
<volume>20</volume>
<issue>15</issue>
<fpage>3022</fpage>
<lpage>3030</lpage>
<pub-id pub-id-type="pmid">21551454</pub-id>
</element-citation>
</ref>
<ref id="ref13">
<label>13</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boutet</surname>
<given-names>E</given-names>
</name>
<name>
<surname>El</surname>
<given-names>Mourabit H</given-names>
</name>
<name>
<surname>Prot</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Nemani</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Khallouf</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Colard</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Maurice</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Durand-Schneider</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Chretien</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Gres</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Wolf</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Saulnier-Blache</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Capeau</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Magre</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Seipin deficiency alters fatty acid Delta9 desaturation and lipid droplet formation in Berardinelli-Seip congenital lipodystrophy</article-title>
<source/>Biochimie
          <year>2009</year>
<volume>91</volume>
<issue>6</issue>
<fpage>796</fpage>
<lpage>803</lpage>
<pub-id pub-id-type="pmid">19278620</pub-id>
</element-citation>
</ref>
<ref id="ref14">
<label>14</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Binns</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hilton</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>QX</given-names>
</name>
<name>
<surname>Goodman</surname>
<given-names>JM</given-names>
</name>
</person-group>
<article-title>Seipin is a discrete homooligomer</article-title>
<source/>Biochemistry
          <year>2010</year>
<volume>49</volume>
<issue>50</issue>
<fpage>10747</fpage>
<lpage>10755</lpage>
<pub-id pub-id-type="pmid">21062080</pub-id>
</element-citation>
</ref>
<ref id="ref15">
<label>15</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ito</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Fujisawa</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Iida</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Suzuki</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>Characterization of seipin/BSCL2, a protein associated with spastic paraplegia 17</article-title>
<source/>Neurobiology of disease
          <year>2008</year>
<volume>31</volume>
<issue>2</issue>
<fpage>266</fpage>
<lpage>277</lpage>
<pub-id pub-id-type="pmid">18585921</pub-id>
</element-citation>
</ref>
<ref id="ref16">
<label>16</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wei</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Soh</surname>
<given-names>SL</given-names>
</name>
<name>
<surname>Qiu</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Seah</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Ong</surname>
<given-names>WY</given-names>
</name>
<name>
<surname>Pang</surname>
<given-names>ZP</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>W</given-names>
</name>
</person-group>
<article-title>Seipin regulates excitatory synaptic transmission in cortical neurons</article-title>
<source/>Journal of neurochemistry
          <year>2013</year>
<volume>124</volume>
<issue>4</issue>
<fpage>478</fpage>
<lpage>489</lpage>
<pub-id pub-id-type="pmid">23173741</pub-id>
</element-citation>
</ref>
<ref id="ref17">
<label>17</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Van Maldergem</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Magre</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Khallouf</surname>
<given-names>TE</given-names>
</name>
<name>
<surname>Gedde-Dahl</surname>
<given-names>T</given-names>
<suffix>Jr</suffix>
</name>
<name>
<surname>Delepine</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Trygstad</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Seemanova</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Stephenson</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Albott</surname>
<given-names>CS</given-names>
</name>
<name>
<surname>Bonnici</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Panz</surname>
<given-names>VR</given-names>
</name>
<name>
<surname>Medina</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Bogalho</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Huet</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Savasta</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Verloes</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Robert</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Loret</surname>
<given-names>H</given-names>
</name>
<name>
<surname>De Kerdanet</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Tubiana-Rufi</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Megarbane</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Maassen</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Polak</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lacombe</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Kahn</surname>
<given-names>CR</given-names>
</name>
<name>
<surname>Silveira</surname>
<given-names>EL</given-names>
</name>
<name>
<surname>D’Abronzo</surname>
<given-names>FH</given-names>
</name>
<name>
<surname>Grigorescu</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Lathrop</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Capeau</surname>
<given-names>J</given-names>
</name>
<name>
<surname>O’Rahilly</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Genotype-phenotype relationships in Berardinelli-Seip congenital lipodystrophy</article-title>
<source/>Journal of medical genetics
          <year>2002</year>
<volume>39</volume>
<issue>10</issue>
<fpage>722</fpage>
<lpage>733</lpage>
<pub-id pub-id-type="pmid">12362029</pub-id>
</element-citation>
</ref>
<ref id="ref18">
<label>18</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wei</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Soh</surname>
<given-names>SL</given-names>
</name>
<name>
<surname>Xia</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Ong</surname>
<given-names>WY</given-names>
</name>
<name>
<surname>Pang</surname>
<given-names>ZP</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>W</given-names>
</name>
</person-group>
<article-title>Motor neuropathy-associated mutation impairs Seipin functions in neurotransmission</article-title>
<source/>Journal of neurochemistry
          <year>2014</year>
<volume>129</volume>
<issue>2</issue>
<fpage>328</fpage>
<lpage>338</lpage>
<pub-id pub-id-type="pmid">24345054</pub-id>
</element-citation>
</ref>
<ref id="ref19">
<label>19</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ito</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Suzuki</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>Seipinopathy: a novel endoplasmic reticulum stress-associated disease</article-title>
<source/>Brain
          <year>2009</year>
<volume>132</volume>
<issue>Pt 1</issue>
<fpage>8</fpage>
<lpage>15</lpage>
<pub-id pub-id-type="pmid">18790819</pub-id>
</element-citation>
</ref>
<ref id="ref20">
<label>20</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guillen-Navarro</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Sanchez-Iglesias</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Domingo-Jimenez</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Victoria</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Ruiz-Riquelme</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Rabano</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Loidi</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Beiras</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Gonzalez-Mendez</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Ramos</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Lopez-Gonzalez</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Ballesta-Martinez</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Garrido-Pumar</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Aguiar</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Ruibal</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Requena</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Araujo-Vilar</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>A new seipin-associated neurodegenerative syndrome</article-title>
<source/>Journal of medical genetics
          <year>2013</year>
<volume>50</volume>
<issue>6</issue>
<fpage>401</fpage>
<lpage>409</lpage>
<pub-id pub-id-type="pmid">23564749</pub-id>
</element-citation>
</ref>
<ref id="ref21">
<label>21</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kircher</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Witten</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Jain</surname>
<given-names>P</given-names>
</name>
<name>
<surname>O’Roak</surname>
<given-names>BJ</given-names>
</name>
<name>
<surname>Cooper</surname>
<given-names>GM</given-names>
</name>
<name>
<surname>Shendure</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>A general framework for estimating the relative pathogenicity of human genetic variants</article-title>
<source/>Nature genetics
          <year>2014</year>
<volume>46</volume>
<fpage>310</fpage>
<lpage>315</lpage>
<pub-id pub-id-type="pmid">24487276</pub-id>
</element-citation>
</ref>
<ref id="ref22">
<label>22</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schwarz</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Cooper</surname>
<given-names>DN</given-names>
</name>
<name>
<surname>Schuelke</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Seelow</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>MutationTaster2: mutation prediction for the deep-sequencing age</article-title>
<source/>Nature methods
          <year>2014</year>
<volume>11</volume>
<issue>4</issue>
<fpage>361</fpage>
<lpage>362</lpage>
<pub-id pub-id-type="pmid">24681721</pub-id>
</element-citation>
</ref>
<ref id="ref23">
<label>23</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gilissen</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Hoischen</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Brunner</surname>
<given-names>HG</given-names>
</name>
<name>
<surname>Veltman</surname>
<given-names>JA</given-names>
</name>
</person-group>
<article-title>Unlocking Mendelian disease using exome sequencing</article-title>
<source/>Genome biology
          <year>2011</year>
<volume>12</volume>
<issue>9</issue>
<fpage>228</fpage>
<pub-id pub-id-type="pmid">21920049</pub-id>
</element-citation>
</ref>
<ref id="ref24">
<label>24</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Choi</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Woo</surname>
<given-names>HI</given-names>
</name>
<name>
<surname>Choe</surname>
<given-names>BH</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Yoon</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Ki</surname>
<given-names>CS</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>SY</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>JW</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>DS</given-names>
</name>
<name>
<surname>Kwon</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>HD</given-names>
</name>
</person-group>
<article-title>Application of whole exome sequencing to a rare inherited metabolic disease with neurological and gastrointestinal manifestations: a congenital disorder of glycosylation mimicking glycogen storage disease</article-title>
<source/>Clinica chimica acta
          <year>2015</year>
<volume>444</volume>
<fpage>50</fpage>
<lpage>53</lpage>
</element-citation>
</ref>
<ref id="ref25">
<label>25</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barcena</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Quesada</surname>
<given-names>V</given-names>
</name>
<name>
<surname>De</surname>
<given-names>Sandre-Giovannoli A</given-names>
</name>
<name>
<surname>Puente</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Fernandez-Toral</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Sigaudy</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Baban</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Levy</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Velasco</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Lopez-Otin</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Exome sequencing identifies a novel mutation in PIK3R1 as the cause of SHORT syndrome</article-title>
<source/>BMC medical genetics
          <year>2014</year>
<volume>15</volume>
<fpage>51</fpage>
<pub-id pub-id-type="pmid">24886349</pub-id>
</element-citation>
</ref>
<ref id="ref26">
<label>26</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kevelam</surname>
<given-names>SH</given-names>
</name>
<name>
<surname>Bugiani</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Salomons</surname>
<given-names>GS</given-names>
</name>
<name>
<surname>Feigenbaum</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Blaser</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Prasad</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Haberle</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Baric</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Bakker</surname>
<given-names>IM</given-names>
</name>
<name>
<surname>Postma</surname>
<given-names>NL</given-names>
</name>
<name>
<surname>Kanhai</surname>
<given-names>WA</given-names>
</name>
<name>
<surname>Wolf</surname>
<given-names>NI</given-names>
</name>
<name>
<surname>Abbink</surname>
<given-names>TE</given-names>
</name>
<name>
<surname>Waisfisz</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Heutink</surname>
<given-names>P</given-names>
</name>
<name>
<surname>van der Knaap</surname>
<given-names>MS</given-names>
</name>
</person-group>
<article-title>Exome sequencing reveals mutated SLC19A3 in patients with an early-infantile, lethal encephalopathy</article-title>
<source/>Brain
          <year>2013</year>
<volume>136</volume>
<issue>Pt 5</issue>
<fpage>1534</fpage>
<lpage>1543</lpage>
<pub-id pub-id-type="pmid">23482991</pub-id>
</element-citation>
</ref>
<ref id="ref27">
<label>27</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Drew</surname>
<given-names>AP</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Kidambi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ly</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Tey</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Brewer</surname>
<given-names>MH</given-names>
</name>
<name>
<surname>Ahmad-Annuar</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Nicholson</surname>
<given-names>GA</given-names>
</name>
<name>
<surname>Kennerson</surname>
<given-names>ML</given-names>
</name>
</person-group>
<article-title>Improved inherited peripheral neuropathy genetic diagnosis by whole-exome sequencing</article-title>
<source/>Molecular genetics and genomic medicine
          <year>2015</year>
<volume>3</volume>
<issue>2</issue>
<fpage>143</fpage>
<lpage>154</lpage>
<pub-id pub-id-type="pmid">25802885</pub-id>
</element-citation>
</ref>
<ref id="ref28">
<label>28</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Delmiro</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Rivera</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Garcia-Silva</surname>
<given-names>MT</given-names>
</name>
<name>
<surname>Garcia-Consuegra</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Martin-Hernandez</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Quijada-Fraile</surname>
<given-names>P</given-names>
</name>
<name>
<surname>de Las Heras</surname>
<given-names>RS</given-names>
</name>
<name>
<surname>Moreno-Izquierdo</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Arenas</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Martinez-Azorin</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>Whole-exome sequencing identifies a variant of the mitochondrial MT-ND1 gene associated with epileptic encephalopathy: west syndrome evolving to Lennox-Gastaut syndrome</article-title>
<source/>Human mutation
          <year>2013</year>
<volume>34</volume>
<issue>12</issue>
<fpage>1623</fpage>
<lpage>1627</lpage>
<pub-id pub-id-type="pmid">24105702</pub-id>
</element-citation>
</ref>
<ref id="ref29">
<label>29</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pierson</surname>
<given-names>TM</given-names>
</name>
<name>
<surname>Adams</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Markello</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Golas</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sincan</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Simeonov</surname>
<given-names>DR</given-names>
</name>
<name>
<surname>Fuentes Fajardo</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Hansen</surname>
<given-names>NF</given-names>
</name>
<name>
<surname>Cherukuri</surname>
<given-names>PF</given-names>
</name>
<name>
<surname>Cruz</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Teer</surname>
<given-names>JK</given-names>
</name>
<name>
<surname>Mullikin</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Program</surname>
<given-names>NCS</given-names>
</name>
<name>
<surname>Boerkoel</surname>
<given-names>CF</given-names>
</name>
<name>
<surname>Gahl</surname>
<given-names>WA</given-names>
</name>
<name>
<surname>Tifft</surname>
<given-names>CJ</given-names>
</name>
</person-group>
<article-title>Exome sequencing as a diagnostic tool in a case of undiagnosed juvenile-onset GM1-gangliosidosis</article-title>
<source/>Neurology
          <year>2012</year>
<volume>79</volume>
<issue>2</issue>
<fpage>123</fpage>
<lpage>126</lpage>
<pub-id pub-id-type="pmid">22675082</pub-id>
</element-citation>
</ref>
<ref id="ref30">
<label>30</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Garg</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kircher</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Del</surname>
<given-names>Campo M</given-names>
</name>
<name>
<surname>Amato</surname>
<given-names>RS</given-names>
</name>
<name>
<surname>Agarwal</surname>
<given-names>AK</given-names>
</name>
</person-group>
<article-title>University of Washington Center for Mendelian G. Whole exome sequencing identifies de novo heterozygous CAV1 mutations associated with a novel neonatal onset lipodystrophy syndrome</article-title>
<source/>American journal of medical genetics part A
          <year>2015</year>
<volume>167A</volume>
<issue>8</issue>
<fpage>1796</fpage>
<lpage>1806</lpage>
<pub-id pub-id-type="pmid">25898808</pub-id>
</element-citation>
</ref>
<ref id="ref31">
<label>31</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dauber</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Stoler</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Hechter</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Safer</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Hirschhorn</surname>
<given-names>JN</given-names>
</name>
</person-group>
<article-title>Whole exome sequencing reveals a novel mutation in CUL7 in a patient with an undiagnosed growth disorder</article-title>
<source/>The journal of pediatrics
          <year>2013</year>
<volume>162</volume>
<issue>1</issue>
<fpage>202</fpage>
<lpage>204</lpage>
<pub-id pub-id-type="pmid">22974575</pub-id>
</element-citation>
</ref>
<ref id="ref32">
<label>32</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schuster</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Khan</surname>
<given-names>TN</given-names>
</name>
<name>
<surname>Tariq</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Shaiq</surname>
<given-names>PA</given-names>
</name>
<name>
<surname>Mabert</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Baig</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Klar</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Exome sequencing circumvents missing clinical data and identifies a BSCL2 mutation in congenital lipodystrophy</article-title>
<source/>BMC medical genetics
          <year>2014</year>
<volume>15</volume>
<fpage>71</fpage>
<pub-id pub-id-type="pmid">24961962</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>